| Signatures of mutational processes in human cancer LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ... nature 500 (7463), 415-421, 2013 | 10203 | 2013 |
| Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer NA Rizvi, MD Hellmann, A Snyder, P Kvistborg, V Makarov, JJ Havel, ... Science 348 (6230), 124-128, 2015 | 8287 | 2015 |
| Neoantigens in cancer immunotherapy TN Schumacher, RD Schreiber Science 348 (6230), 69-74, 2015 | 5004 | 2015 |
| Mutations associated with acquired resistance to PD-1 blockade in melanoma JM Zaretsky, A Garcia-Diaz, DS Shin, H Escuin-Ordinas, W Hugo, ... New England Journal of Medicine 375 (9), 819-829, 2016 | 3058 | 2016 |
| Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens MM Gubin, X Zhang, H Schuster, E Caron, JP Ward, T Noguchi, Y Ivanova, ... Nature 515 (7528), 577-581, 2014 | 2172 | 2014 |
| The human cell atlas A Regev, SA Teichmann, ES Lander, I Amit, C Benoist, E Birney, ... elife 6, e27041, 2017 | 2149 | 2017 |
| Regulation and function of the PD-L1 checkpoint C Sun, R Mezzadra, TN Schumacher Immunity 48 (3), 434-452, 2018 | 1871 | 2018 |
| B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 | 1868 | 2020 |
| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1850 | 2019 |
| Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative … RPM Sutmuller, LM van Duivenvoorde, A van Elsas, TNM Schumacher, ... The Journal of experimental medicine 194 (6), 823-832, 2001 | 1314 | 2001 |
| Defining ‘T cell exhaustion’ CU Blank, WN Haining, W Held, PG Hogan, A Kallies, E Lugli, RC Lynn, ... Nature Reviews Immunology 19 (11), 665-674, 2019 | 1194 | 2019 |
| Empty MHC class I molecules come out in the cold HG Ljunggren, NJ Stam, C Öhlén, JJ Neefjes, P Höglund, MT Heemels, ... Nature 346 (6283), 476-480, 1990 | 1151 | 1990 |
| Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers M Chalabi, LF Fanchi, KK Dijkstra, JG Van den Berg, AG Aalbers, ... Nature medicine 26 (4), 566-576, 2020 | 1066 | 2020 |
| T cell dysfunction in cancer DS Thommen, TN Schumacher Cancer cell 33 (4), 547-562, 2018 | 1053 | 2018 |
| CD8+ T cell states in human cancer: insights from single-cell analysis AM Van der Leun, DS Thommen, TN Schumacher Nature Reviews Cancer 20 (4), 218-232, 2020 | 1047 | 2020 |
| A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade DS Thommen, VH Koelzer, P Herzig, A Roller, M Trefny, S Dimeloe, ... Nature medicine 24 (7), 994-1004, 2018 | 966 | 2018 |
| Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma N van Rooij, MM van Buuren, D Philips, A Velds, M Toebes, B Heemskerk, ... Journal of Clinical Oncology 31 (32), e439-e442, 2013 | 964 | 2013 |
| Generation of peptide–MHC class I complexes through UV-mediated ligand exchange B Rodenko, M Toebes, SR Hadrup, WJE Van Esch, AM Molenaar, ... Nature protocols 1 (3), 1120-1132, 2006 | 943 | 2006 |
| CD27 is required for generation and long-term maintenance of T cell immunity J Hendriks, LA Gravestein, K Tesselaar, RAW Van Lier, TNM Schumacher, ... Nature immunology 1 (5), 433-440, 2000 | 942 | 2000 |
| Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma H Li, AM van der Leun, I Yofe, Y Lubling, D Gelbard-Solodkin, ... Cell 176 (4), 775-789. e18, 2019 | 914 | 2019 |
Pia Kvistborgsenior scientistVerified email at nki.nl
